Medical community hopeful following FDA’s accelerated approval for Alzheimer’s disease treatment
Drs. Steven DeKosky and Glenn Smith discuss Lecanemab for WUFT article.
Drs. Steven DeKosky and Glenn Smith discuss Lecanemab for WUFT article.
Dr. Steven DeKosky has been cited over 100K times, per Google Scholar.
Dr. Steven DeKosky provides indicators to help “guestimate” rate of cognitive decline.
Conversation article co-authored by Drs. Steven DeKosky and Michael Jaffee discusses new research about dementia and COVID-19 risk.
View a recording of Drs. Todd Golde and Steven DeKosky’s UF Health Webinar.
In The Conversation, Drs. Golde and DeKosky explain the new test, which shows high accuracy in detecting chemicals specific to Alzheimer’s.
In her new role, Dr. Jada Lewis will continue to focus on the MBI's education and outreach activities.
In the journal Science, MBI leaders Drs. Steven DeKosky and Todd Golde discuss the challenges of developing effective Alzheimer's therapies and the road ahead.
Dr. Steven DeKosky, M.D., was listed among the most influential authors in his field worldwide based on frequency of citations by peers.
Retired Col. Dr. Michael Jaffee and Dr. Steven DeKosky explain military-related risks of developing dementia that are detailed in a new paper in the journal Alzheimer’s & Dementia.